» Articles » PMID: 32778085

Socio-demographic Correlates of First Dose of Measles (MCV1) Vaccination Coverage in India

Overview
Publisher Biomed Central
Specialty Public Health
Date 2020 Aug 12
PMID 32778085
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Between 2010 and 2018, measles-related mortality had halved in India mainly with effective measles vaccination campaigns and widespread coverage across the states and population subgroups. Despite the commendable vaccination coverage, 2.9 million children in India missed the first dose of measles vaccine (MCV1) in 2017, and many of those vaccinated were not vaccinated at the recommended age (i.e. between 9 and 12 months). This study analyzed pattern and correlates of MCV1 coverage and MCV1 administration at recommended age among children aged 12-23 months in India.

Methods: We used the official data from the recent round of National Family Health Survey (NFHS-4), a nationally representative cross-sectional household survey in India conducted in 2015-16. Descriptive statistics and logistic regression analysis were applied to ascertain the influence of specified socio-demographic variables affecting measles vaccination coverage in India.

Results: The study revealed the distinct variations in coverage of MCV1 between the districts of India. There were also major challenges with age recommended vaccination, with about 15% of eligible children not vaccinated within the recommended age range, attributable to several socio-demographic factors. Significantly, antenatal care utilization of mothers strongly influenced MCV1 coverage and age recommended MCV1 coverage in India. The study also identified that children who missed MCV1 had one or more adverse health risks such as malnutrition, anemia and diarrhea disease.

Conclusions: A socio-economic gradient exists in India's MCV1 coverage, mediated by antenatal visits, education of mothers, and highlighted socio-demographic factors. Infection with measles was significantly correlated with greater anthropometric deficits among the study cohort, indicating a wider range of benefits from preventing measles infection. Eliminating morbidity and mortality from measles in India is feasible, although it will require efficient expanded program on immunization management, enhanced health literacy among mothers, continuing commitment from central state and district political authorities.

Citing Articles

Coverage of Second Dose of Measles-Containing Vaccine (MCV-2) and Japanese Encephalitis Vaccine (JE-2) and Its Predictors Among Children 2-5 Years Old in the Ormanjhi Block of Ranchi, Jharkhand, India: A Mixed Method Study.

Mukul A, Singh S, Sagar V, Paswan D, Narain S, Kumar D Cureus. 2024; 16(11):e73004.

PMID: 39640145 PMC: 11617491. DOI: 10.7759/cureus.73004.


Are we really hesitant toward routine immunization: Findings from a cross-sectional study in urban area in the tribal dominant state of India.

Kiran K, Kujur A, Kumar D, Sagar V, Kumari N, Anand P J Family Med Prim Care. 2024; 13(9):4001-4007.

PMID: 39464915 PMC: 11504838. DOI: 10.4103/jfmpc.jfmpc_423_24.


Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.

Dhalaria P, Kumar P, Verma A, Priyadarshini P, Singh A, Tripathi B Vaccine. 2024; 42(17):3637-3646.

PMID: 38704248 PMC: 11165302. DOI: 10.1016/j.vaccine.2024.04.075.

References
1.
Dabbagh A, Patel M, Dumolard L, Gacic-Dobo M, Mulders M, Okwo-Bele J . Progress Toward Regional Measles Elimination - Worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017; 66(42):1148-1153. PMC: 5689104. DOI: 10.15585/mmwr.mm6642a6. View

2.
Faneye A, Adeniji J, Olusola B, Motayo B, Akintunde G . Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria. Viral Immunol. 2015; 28(6):304-8. PMC: 4507133. DOI: 10.1089/vim.2014.0118. View

3.
Scobie H, Ray A, Routray S, Bose A, Bahl S, Sosler S . Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012. PLoS One. 2015; 10(5):e0127105. PMC: 4444104. DOI: 10.1371/journal.pone.0127105. View

4.
McKee A, Ferrari M, Shea K . Correlation between measles vaccine doses: implications for the maintenance of elimination. Epidemiol Infect. 2018; 146(4):468-475. PMC: 5848754. DOI: 10.1017/S0950268817003077. View

5.
Sarkar S, Zlojutro A, Khan K, Gardner L . Measles resurgence in the USA: how international travel compounds vaccine resistance. Lancet Infect Dis. 2019; 19(7):684-686. DOI: 10.1016/S1473-3099(19)30231-2. View